Prognostic Factors in Pulmonary Metastasized High-Grade Osteosarcoma

被引:70
作者
Buddingh, Emilie P. [2 ]
Anninga, Jakob K. [2 ]
Versteegh, Michel I. M. [3 ]
Taminiau, Antonie H. M.
Egeler, R. Maarten [2 ]
van Rijswijk, Catherina S. P. [4 ]
Hogendoorn, Pancras C. W. [5 ]
Lankester, Arjan C. [2 ]
Gelderblom, Hans [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Pediat Hematol Oncol & Bone Marrow Transplan, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Cardiothorac Surg, NL-2300 RC Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Orthoped Surg, NL-2300 RC Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
关键词
bone neoplasm; metastasis; osteosarcoma; prognosis; survival; NEOADJUVANT CHEMOTHERAPY; METASTATIC LESIONS; SINGLE INSTITUTION; BONE SARCOMAS; SURVIVAL; EXPERIENCE; INTERGROUP; RESECTION; METASTASECTOMY; EXTREMITIES;
D O I
10.1002/pbc.22293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. Resection of pulmonary metastases has previously been reported to improve Outcome in high-grade osteosarcoma (OS) patients. Factors influencing Survival in OS patients with pulmonary metastases are important for clinical decision making. Methods. All 88 OS patients with pulmonary metastases either at diagnosis or during follow-up treated at the Leiden University Medical Center between January 1, 1990 and January 1, 2008 under the age of 40 were included in this Study, including 79 cases of conventional, 8 cases of telangiectatic and 1 case of small cell OS. Results. In total, 56 of 88 patients with pulmonary metastases were treated by metastasectomy. Resectability Of pulmonary metastases was the main prognostic factor. In patients with primary non-metastatic OS, a longer relapse free interval to Pulmonary metastases was significantly associated with better survival (P=0.02). Independent risk factors determining worse survival after metastasectomy in multivariate analysis were male sex (P=0.05), higher number of pulmonary nodules (P=0.03), and non-necrotic metastases (P=0.04). Whether Surgery for recurrent pulmonary metastases was performed did not influence Survival. Histological Subtype of the primary tumor, histological response in the primary tumor after neoadjuvant chemotherapy, occurrence of local relapse, local resection or amputation of the primary tumor and age at diagnosis did not influence Outcome. Conclusion. This cohort of patients with detailed follow-up data enabled US to identify important risk factors determining Survival in OS patients with pulmonary metastases. We demonstrate that after repeated metastasectomies, a subset of patients can be cured. Pediatr Blood Cancer 2010;54:216-221. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:216 / 221
页数:6
相关论文
共 30 条
  • [1] Management of high-grade bone sarcomas over two decades:: The Norwegian Radium Hospital experience
    Aksnes, LH
    Hall, KS
    Folleraas, G
    Stenwig, AE
    Bjerkehagen, B
    Taksdal, I
    Winderen, M
    Bruland, OS
    Sæter, G
    [J]. ACTA ONCOLOGICA, 2006, 45 (01) : 38 - 46
  • [2] Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution
    Bacci, G
    Longhi, A
    Versari, M
    Mercuri, M
    Briccoli, A
    Picci, P
    [J]. CANCER, 2006, 106 (05) : 1154 - 1161
  • [3] Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy
    Bacci, G
    Briccoli, A
    Longhi, A
    Ferrari, S
    Mercuri, M
    Faggioli, F
    Versari, M
    Picci, P
    [J]. ACTA ONCOLOGICA, 2005, 44 (07) : 748 - 755
  • [4] High Grade Osteosarcoma of the Extremities With Lung Metastases at Presentation: Treatment With Neoadjuvant Chemotherapy and Simultaneous Resection of Primary and Metastatic Lesions
    Bacci, Gaetano
    Rocca, Michele
    Salone, Mariacristina
    Balladelli, Alba
    Ferrari, Stefano
    Palmerini, Emanuela
    Forni, Cristiana
    Briccoli, Antonio
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (06) : 415 - 420
  • [5] Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
    Bielack, SS
    Kempf-Bielack, B
    Delling, G
    Exner, GU
    Flege, S
    Helmke, K
    Kotz, R
    Salzer-Kuntschik, M
    Werner, M
    Winkelmann, W
    Zoubek, A
    Jürgens, H
    Winkler, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) : 776 - 790
  • [6] Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients
    Bielack, Stefan S.
    Kempf-Bielack, Beate
    Branscheid, Detlev
    Carrle, Dorothe
    Friedel, Godehard
    Helmke, Knut
    Kevric, Matthias
    Jundt, Gernot
    Kuehne, Thomas
    Maas, Rainer
    Schwarz, Rudolf
    Zoubek, Andreas
    Juergens, Heribert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 557 - 565
  • [7] Resection of recurrent pulmonary metastases in patients with osteosarcoma
    Briccoli, A
    Rocca, M
    Salone, M
    Bacci, G
    Ferrari, S
    Balladelli, A
    Mercuri, M
    [J]. CANCER, 2005, 104 (08) : 1721 - 1725
  • [8] Treatment of osteosarcoma at first recurrence after contemporary therapy - The Memorial Sloan-Kettering Cancer Center Experience
    Chou, AJ
    Merola, PR
    Wexler, LH
    Gorlick, RG
    Vyas, YM
    Healey, JH
    LaQuaglia, MP
    Huvos, AG
    Meyers, PA
    [J]. CANCER, 2005, 104 (10) : 2214 - 2221
  • [9] Survival after recurrence of osteosarcoma: A 20-year experience at a single institution
    Crompton, Brian D.
    Goldsby, Robert E.
    Weinberg, Vivian K.
    Feren, Robert
    O'Donnell, Richard J.
    Ablin, Arthur R.
    [J]. PEDIATRIC BLOOD & CANCER, 2006, 47 (03) : 255 - 259
  • [10] Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma
    Dohi, Osamu
    Hatori, Masahito
    Suzuki, Takashi
    Ono, Katsuhiko
    Hosaka, Masami
    Akahira, Jun-ichi
    Miki, Yasuhiro
    Nagasaki, Shuji
    Itoi, Eiji
    Sasano, Hironobu
    [J]. CANCER SCIENCE, 2008, 99 (03) : 518 - 523